Ranbaxy Laboratories’ wholly owned subsidiary Ranbaxy Laboratories Inc (RLI) has received US Food and Drug Administration (USFDA) approval for Absorica, a novel, patented brand formulation of the acne medication isotretinoin, developed by Cipher, for the treatment of severe recalcitrant nodular acne.
Through a business agreement with the Canadian firm, Cipher Pharmaceutical Inc, RLI is expected to launch Absorica in the US in Q4 2012; as per the agreement, Ranbaxy will pay royalties on net sales to Cipher.
Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1867.80 |
| Dr. Reddys Labs. | 1301.30 |
| Cipla | 1433.10 |
| Zydus Lifesciences | 1112.10 |
| Lupin | 2356.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: